• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A vital gene for modified vaccinia virus Ankara replication in human cells.

作者信息

Sutter Gerd

机构信息

Division of Virology, Institute for Infectious Diseases and Zoonoses, Ludwig-Maximilians-Universität München, 80539 München, Germany;

Division of Virology, Institute for Infectious Diseases and Zoonoses, German Center for Infection Research, 80539 München, Germany.

出版信息

Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6289-6291. doi: 10.1073/pnas.2001335117. Epub 2020 Mar 16.

DOI:10.1073/pnas.2001335117
PMID:32179684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7104218/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb6/7104218/a1642df0597a/pnas.2001335117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb6/7104218/a1642df0597a/pnas.2001335117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/beb6/7104218/a1642df0597a/pnas.2001335117fig01.jpg

相似文献

1
A vital gene for modified vaccinia virus Ankara replication in human cells.用于改良安卡拉痘苗病毒在人细胞中复制的一个关键基因。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6289-6291. doi: 10.1073/pnas.2001335117. Epub 2020 Mar 16.
2
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.SPI-1 是一种缺失的宿主范围因子，对于减毒的改良安卡拉牛痘（MVA）疫苗载体在人细胞中的复制是必需的。
PLoS Pathog. 2019 May 30;15(5):e1007710. doi: 10.1371/journal.ppat.1007710. eCollection 2019 May.
3
Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.改良安卡拉痘苗病毒在原代鸡胚成纤维细胞中的复制需要干扰素抗性基因E3L的表达。
J Virol. 2003 Aug;77(15):8394-407. doi: 10.1128/jvi.77.15.8394-8407.2003.
4
Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.水痘病毒 C7/K1 双缺失突变体的人类宿主范围限制是由一种非典型的翻译抑制模式介导的。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01329-18. Print 2018 Dec 1.
5
Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.痘苗病毒安卡拉株宿主范围限制缺陷的标志物拯救
Virology. 1998 Nov 25;251(2):334-42. doi: 10.1006/viro.1998.9397.
6
Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant.通过人全基因组RNA干扰筛选病毒宿主范围突变体鉴定限制因子：以发现SAMD9和WDR6作为痘苗病毒K1L - C7L突变体抑制剂为例
mBio. 2015 Aug 4;6(4):e01122. doi: 10.1128/mBio.01122-15.
7
Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.用改良安卡拉痘苗病毒和痘苗病毒感染人树突状细胞后病毒生命周期进展和宿主细胞生理学的差异与相似性。
J Virol. 2006 Sep;80(17):8469-81. doi: 10.1128/JVI.02749-05.
8
Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification.实验进化鉴定出痘苗病毒A24R和A35R基因中的突变，这些突变拮抗蛋白激酶R通路并伴随一个基因外基因扩增的崩溃。
J Virol. 2015 Oct;89(19):9986-97. doi: 10.1128/JVI.01233-15. Epub 2015 Jul 22.
9
Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice.牛痘病毒 F5 对于在多种细胞系中形成正常空斑形态是必需的，但对于在培养物中的复制或在小鼠中的毒力并非必需。
Virology. 2014 May;456-457:145-56. doi: 10.1016/j.virol.2014.03.020. Epub 2014 Apr 5.
10
Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.改良安卡拉痘苗病毒：固有免疫激活和细胞信号诱导。
Vaccine. 2013 Sep 6;31(39):4231-4. doi: 10.1016/j.vaccine.2013.03.017. Epub 2013 Mar 21.

引用本文的文献

1
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection.在致死性寨卡病毒感染快速攻击模型中，孕妇紧急接种MVA-ZIKV疫苗的效果。
NPJ Vaccines. 2025 Mar 5;10(1):44. doi: 10.1038/s41541-025-01094-0.
2
Molecular evolution of 2022 multi-country outbreak-causing monkeypox virus Clade IIb.2022年多国猴痘疫情致病病毒分支IIb的分子进化
iScience. 2023 Dec 1;27(1):108601. doi: 10.1016/j.isci.2023.108601. eCollection 2024 Jan 19.
3
Lumpy Skin Disease Virus Genome Sequence Analysis: Putative Spatio-Temporal Epidemiology, Single Gene versus Whole Genome Phylogeny and Genomic Evolution.

本文引用的文献

1
Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.先前未被描述的第二宿主范围基因的修复有助于改良安卡拉痘苗病毒（MVA）在人细胞中的完全复制。
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3759-3767. doi: 10.1073/pnas.1921098117. Epub 2020 Feb 4.
2
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.SPI-1 是一种缺失的宿主范围因子，对于减毒的改良安卡拉牛痘（MVA）疫苗载体在人细胞中的复制是必需的。
PLoS Pathog. 2019 May 30;15(5):e1007710. doi: 10.1371/journal.ppat.1007710. eCollection 2019 May.
3
《块状皮肤疾病病毒基因组序列分析：疑似时空流行病学、单基因与全基因组系统发生学及基因组进化》
Viruses. 2023 Jun 28;15(7):1471. doi: 10.3390/v15071471.
4
Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.基于重组痘苗病毒载体的接种部位疫苗学揭示了多样化的固有免疫特征。
PLoS Pathog. 2021 Jan 13;17(1):e1009215. doi: 10.1371/journal.ppat.1009215. eCollection 2021 Jan.
Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant Roles.
痘病毒基因组脱壳和具有相互冗余作用的DNA复制因子的鉴定
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.02152-17. Print 2018 Apr 1.
4
Triad of human cellular proteins, IRF2, FAM111A, and RFC3, restrict replication of orthopoxvirus SPI-1 host-range mutants.三种人类细胞蛋白（IRF2、FAM111A 和 RFC3）限制正痘病毒 SPI-1 宿主范围突变体的复制。
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3720-3725. doi: 10.1073/pnas.1700678114. Epub 2017 Mar 20.
5
Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.安卡拉改良牛痘病毒：历史、基础研究价值及疫苗开发的当前展望
Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1.
6
Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant.通过人全基因组RNA干扰筛选病毒宿主范围突变体鉴定限制因子：以发现SAMD9和WDR6作为痘苗病毒K1L - C7L突变体抑制剂为例
mBio. 2015 Aug 4;6(4):e01122. doi: 10.1128/mBio.01122-15.
7
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.基于改良安卡拉痘苗病毒（MVA）载体的基因治疗或疫苗接种的生物安全方面。
Vaccine. 2012 Mar 30;30(16):2623-32. doi: 10.1016/j.vaccine.2012.02.016. Epub 2012 Feb 17.
8
Identification from diverse mammalian poxviruses of host-range regulatory genes functioning equivalently to vaccinia virus C7L.从多种哺乳动物痘病毒中鉴定出功能等同于痘苗病毒C7L的宿主范围调控基因。
Virology. 2008 Mar 15;372(2):372-83. doi: 10.1016/j.virol.2007.10.023. Epub 2007 Dec 3.
9
Poxvirus tropism.痘病毒嗜性
Nat Rev Microbiol. 2005 Mar;3(3):201-13. doi: 10.1038/nrmicro1099.
10
Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.痘苗病毒安卡拉株宿主范围限制缺陷的标志物拯救
Virology. 1998 Nov 25;251(2):334-42. doi: 10.1006/viro.1998.9397.